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Objective: The aim of this study is to compare a cognitive behavioral group therapy
(CBT) with a health enhancement program (HEP) for stress reduction and the impact on
quality of life (QoL) in patients with Parkinson’s disease (PD).
Method: Thirty patients with PD participated in the study: 16 received CBT
including stress-reducing elements and 14 took part in a HEP. The two groups
did not differ significantly in their baseline demographic characteristics. The patients
in both groups underwent weekly sessions of 2 h duration for 9 weeks. The
Parkinson’s Disease Questionnaire with 39 items (PDQ-39), the Burden Questionnaire
for Parkinson’s Disease (translated from the original German: Belastungsfragebogen
für Parkinsonpatienten (BELA) and the Disease-Related Questionnaire [Fragebogen zur
krankheitsbezogenen Kommunikation (FKK)] were used for assessment. Ratings were
completed at baseline and after 9 weeks (immediately after the last treatment session).
Results: The patients in the CBT group achieved significantly better BELA, FKK and
PDQ-39 scores (p < 0.05). Subscale analysis revealed that the scores on the BELA
subscales “emotional well-being” and “somatic motor function” contributed significantly
to stress reduction (p < 0.05). The FKK revealed significant improvement in social skills
in the CBT group (p < 0.05).
Conclusion: Cognitive Behavioral Group Therapy appears to be an effective way for
patients with PD to lessen stress and improve their quality of life.
Keywords: cognitive behavioral therapy, Parkinson’s disease, stress, quality of life, non-motor symptoms,
cognitive behavioral group therapy
INTRODUCTION
Parkinson’s disease (PD) is a neurodegenerative disease characterized by both motor and non-
motor dysfunction. The motor manifestations including rigor, tremor, postural instability, and
freezing of gait are well described and commonly recognized (Shulman et al., 2002; Chaudhuri
et al., 2006). The non-motor manifestations such as fatigue, apathy, depression, anxiety, and
sleeplessness have recently attracted increased scientific interest and appear to have a greater impact
on the quality of life (QoL) than the motor manifestations (Richard, 2005; Martinez-Martin, 2011).
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Martínez-Martín (1998, pp. 2–6) defined the health-related
QoL of patients with PD as “the perception and evaluation, by
patients themselves, of the impact caused on their lives by the
disease and its consequences.”
Depression (Weintraub et al., 2004; Martinez-Martin, 2011;
Jones et al., 2015) and anxiety have been found to be associated
with a low QoL (Jones et al., 2015). Soh et al. (2011) analyzed
29 articles that examined predictors of QoL in patients with
PD. Besides motor symptoms, disease severity, and demographic
variables, non-motor symptoms such as apathy, depression, and
anxiety were found to predict QoL. Depression and anxiety
are also negatively associated with the motor symptoms of PD
(Dissanayaka et al., 2011) and the progression of the disease
(Schrag et al., 2000; Leentjens et al., 2013).
Cognitive behavioral therapy (CBT) is an effective treatment
for depression, anxiety, and phobias, in both individual and
group therapy settings (Hofmann et al., 2012). Even in elderly
patients (Peng et al., 2001; Ceri, 2007) and in patients with
neurological diseases, positive effects such as a reduction of
depressive symptoms have been reported (Mohr et al., 2001,
2004). Until now, studies have been focusing on the treatment of
the non-motor symptoms such as depression and anxiety rather
than the improvement of QoL. Dobkin et al. (2011) examined
the impact of individual CBT on depression and anxiety on
80 patients with PD during 10 weeks. The control group only
received four unspecific, short phone calls. Patients receiving
CBT have shown significantly less symptoms of depression
and anxiety than patients in the control group. This study
has shown that individual CBT lessens depressive symptoms
and anxiety in patients with PD. Patients have also reported
an improvement of their QoL (Dobkin et al., 2011, 2012).
A statistical analysis of QoL has not been assessed. Based on
this study, Dobkin et al. (2012) discerned predictive factors of
the effect of CBT on depression and anxiety. The inclusion
of caregivers predicts the effect of the treatment (Dobkin
et al., 2012). Considering the negative impact of non-motor
symptoms on QoL, a focus on the improvement of QoL could
be advantageous.
There have been only a few studies of the use of CBT
to treat QoL and stress in patients with PD. A high stress
level reinforces and establishes motor symptoms (Metz, 2007;
Hemmerle et al., 2012). CBT aims to identify the stress level
and modify negative cognitive beliefs and behaviors (Beck,
1979). Therefore it might yield greater improvement than drug
treatment alone, and any type of effective treatment would be of
considerable clinical significance in view of the high prevalence
of PD (1–2%) (Moreno et al., 2013). Group CBT is more cost-
effective and has similar effects as individual CBT (McDermut
et al., 2001). In addition there is a lack of studies that use
an active control group, which receives the same frequency of
sessions. The health enhancement program (HEP) of MacCoon
et al. (2012) has been developed for the purpose of building
an active control intervention for a mindfulness based stress
study. To fill these gaps in research, the present study examines
a randomized, controlled trial of CBT for reducing stress and
improving QoL in patients with PD, with HEP as a control
intervention.
MATERIALS AND METHODS
Subjects
Patients were recruited through advertisement on a flyer at the
University of Basel and from the movement disorder clinic.
Patients who met the UK Parkinson’s Disease Brain Bank Criteria
for PD were considered eligible for the study. Patients with severe
dementia or physical impairment or with severe neurologic
or psychiatric deficits were excluded. Forty one Patients were
recruited. Eleven patients dropped out either due to health related
problems or because they missed more than 2 sessions or refused
to continue. Of the remaining 30 patients, 16 were assigned
to the CBT group and 14 to the control (HEP) group (see
Figure 1). Their baseline characteristics are given in Table 1
The two groups were comparable in age, educational level, and
sex. All patients gave written informed consent to participation.
The study was approved by the local ethics committee, the
Ethikkommission Zentral- und Nordwestschweiz (verification
number EKNZ: 294/13).
Study Design
Upon inclusion in the study, the patients were allocated to the
two groups by a computer-generated randomization designed to
yield groups that were balanced in terms of size, age, educational
level, and sex. The patients were not told to which group they had
been allocated or what treatment they would receive. The data
were analyzed in blinded fashion.
Treatments
All patients in both groups underwent weekly treatment sessions
for the duration of 2 h for 9 weeks. These sessions took place
at the University Hospital of Basel, Switzerland. For CBT, a
modification of the manual of Ellgring et al. (2006) was used.
Each CBT session included different content: (1) self-observation,
(2) stress reduction, (3) relaxation and enjoyment, (4) expression
of the illness, (5) sadness and depression, (6) seeking help, (7)
role of relatives, (8) relationship with relatives, (9) summary of
all sessions. Family members participated in two of the sessions.
After every session, the new skills had to be practiced once as
homework. CBT was carried out by a clinical psychologist and
a trainee in clinical psychology.
The control group received the HEP (MacCoon et al., 2012)
with the following contents in each session: (1) and (2) music
therapy, (3, 4, and 5) physical activity, (6 and 7) dietary
counseling, (8) medical information by a physician and (9)
summary of all sessions. Clinical psychologists and trainees in
clinical psychology conducted all nine sessions in the control
group. The study design is illustrated in Figure 2.
Measurements
The patients were asked to complete self-rating questionnaires in
German at baseline and after treatment.
PDQ-39
The Parkinson’s Disease Questionnaire 39 (PDQ-39; Jenkinson
et al., 1997) was used to assess QoL. The 39 items scale (e.g., “I
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FIGURE 1 | Participant flow.
have had difficulties to walk 1 km in the last month”) are answered
on a 5 point Likert scale (never; seldom; sometimes; often and
always). The possible total score ranges from 0 to 156. Lower
values are indicating higher QoL.
Belastungsfragebogen für Parkinsonpatienten
Stress was assessed with the Burden Questionnaire for Patients
with Parkinson’s disease, (original name: Belastungsfragebogen
für Parkinsonpatienten (BELA); Macht and Ellgring, 2003). The
questionnaire consists of 34 Items, which are answered on a 4
point Likert scale before a training (reaching from 0-3, e.g., “I feel
anxious: not at all, a little, mostly, always”). After the training,
patients assessed the change of the problem on a 5 point Likert
scale ranging from −2 to 2 (became much worse, a little worse,
stayed the same, became a little better and became much better).
A negative score indicates an exacerbation of the burden after
the training (min. score −40). A score of 0 indicates no change
and a positive score shows a positive change after the training
(maximum score 40).
Fragebogen zur Krankheitsbezogenen
Kommunikation
The Questionnaire for Disease-Related Communication, [original
name: Fragebogen zur krankheitsbezogenen Kommunikation
(FKK); Macht and Ellgring, 2003] was also used to assess stress.
Similar to the BELA, a 4 point Likert scale ranging from 0 to 3
was used to answer the 20 items before the training. The same 5
point Likert scale as described above was used to measure change
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TABLE 1 | Baseline characteristics of the two study groups (means and
standard deviations).
Intervention
group CBT
Control group
HEP
pa
Number of patients 16 14
Age (years) 65 (8.7) 67 (11) 0.62
Sex (number
female)
4 3 0.82
Education (years) 15 (3.4) 15 (3.5) 0.89
Medication (LED) 630 (460.1) 468 (299.7) 0.32
DBS (number who
underwent DBS
surgery)
6 3 0.34
Duration of disease
(years)
15 (8.9) 18 (8.6) 0.96
UPDRS III 88 (71.1) 94 (89) 0.33
MMSE 29 (1.6) 29 (0.8) 0.41
MOCA 26 (2.4) 26 (2.3) 0.83
BDI 8 (6) 8 (4.7) 0.48
BAI 12 (8.1) 10 (8.3) 0.84
AES 32 (9.7) 30 (6.5) 0.59
PFS 49 (12.1) 39 (17.8) 0.16
ESS 8 (5.9) 6 (4.6) 0.38
CBT, Cognitive Behavioral Therapy; HEP, Health Enhancement Program; DBS,
Deep Brain Stimulation; UPDRS III, Unified Parkinson’s Disease Rating Scale
cognitive deficits; MMSE, Mini Mental State Examination; MOCA, Montreal
Cognitive Assessment; BDI, Beck Depression Inventory; BAI, Beck Anxiety
Inventory; AES, Apathy Evaluation Scale; PFS, Parkinson Fatigue Scale; ESS,
Epworth Sleepiness Scale. Data are all means unless otherwise indicated. The
statistical tests used were analysis of variance (ANOVA) and the χ2 test (for sex
and DBS); aSignificant at the 5% level.
after training. The minimal to maximal score before the training
ranges from 0 to 60, and after the training from−40 to 40.
To detect possible confounding variables, the patients and
their family members and neurologists were asked to supply data
of the following types:
UPDRS III
Based on 18 Items, the Unified Parkinson’s Disease Rating Scale
(UPDRS III; Fahn and Elton, 1987) assesses motor involvement
in patients with PD. On a 5 point Likert scale (ranging from 0 to
4) patients evaluate their difficulties by motor impairment in daily
activities (normal; slight; mild; moderate and severe). While 0
points indicates no difficulties, the maximum of 72 points implies
severe difficulties.
Mini Mental State Examination
The Mini Mental State Examination (MMSE; Folstein et al., 1979)
measures the occurrence and severity of cognitive impairment.
In 11 tasks evaluated by a professional, patients can reach a
maximum score of 30 points, meaning no impairment at all.
Scores between 20 and 26 indicate a mild cognitive impairment,
between 10 and 19 a moderate and below 9 a severe cognitive
impairment.
Montreal Cognitive Assessment
In addition to the MMSE, the Montreal Cognitive Assessment
(MOCA; Nasreddine et al., 2005) also assesses cognitive deficits.
The minimum to maximum score of the 11 tasks, instructed by
a professional, ranges from 0 to 30. A score below 23 indicates a
cognitive impairment.
BDI-II
Depressive symptoms were assessed with the German version
of Beck Depression Inventory II (BDID; Hautzinger et al., 2006).
Patients were asked to fill in 21 items. The 4 point Likert scale
ranges from 0 to 3 (“I do not feel sad”; “I am sad all the time”; “I
FIGURE 2 | Study design.
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am so sad and unhappy I can’t stand it”). Total scores range from
0 to 63. A higher score implies more depressive symptoms.
Beck Anxiety Inventory
The German version of the Beck Anxiety Inventory (BAI; Beck
et al., 1988) measures in 21 items on a 4 point Likert scale the
occurrence of sensations related to anxiety (e.g., not at all; a
little; moderate and many). The minimum score is 0, indicating
not feeling any anxiety at all, whereas the maximum score is 63
meaning a high sensation of anxiety.
Apathy Evaluation Scale
The Apathy Evaluation Scale (AES; Lueken et al., 2006) is a self-
rating questionnaire, which evaluates in 18 items the appearance
and severity of apathy. On a 4 point Likert scale patients evaluate
if and how severe the given situation applies to them (not at all;
a little; moderate and many). Item score ranges from 0 to 3. The
total score ranges from 0 to 53, with a higher value indicating a
higher frequency of apathy.
Parkinson Fatigue Scale
To measure the appearance of fatigue, patients filled in the
Parkinson Fatigue Scale (PFS; Brown et al., 2005). The 5 point
Likert scale of the 16 items ranges from 0 to 4 (does not apply
at all; does not apply; whether nor; does apply a little and applies
a lot). A total score of 0 indicates no appearance of apathy, while a
higher value implies a higher frequency of apathy. The maximum
score is 64.
Epworth Sleepiness Scale
To evaluate the quality of sleep, the Epworth Sleepiness Scale (ESS;
Johns, 1991) was used. Eight situations, which can be evaluated
on a 4 point Likert scale in a self-rating fashion, are described. The
item scale ranges from 0 (no likelihood that situation emerges)
to 3 (high likelihood that situation emerges). The total score has
a minimum of 0 and a maximum of 24 points. A higher score
indicates a more severe sleepiness.
We also performed a battery of neurological tests on all
patients at baseline and on follow-up; the results of these tests
will be the subject of a further publication.
Confounding Variables
Statistical analyses were carried out with SPSS (version 22.0.0.0).
Individual missing items were replaced by mean values; entire
missing questionnaires were not included.
The two study groups were compared at baseline to detect
potential confounding variables.
Analysis of variance (ANOVA) and chi-squared tests were
used to detect intergroup differences in age, disease duration,
educational level, medication (levodopa equivalent dose), sex,
motor manifestations (UPDRS III), cognitive deficits (MMS,
MOCA), depression (BDI), anxiety (BAI), apathy (AES), fatigue
(PFS), and sleepiness (ESS).
Intergroup Comparisons of Changes in
Scores
The effect of training was assessed by the differences between the
patients’ PDQ-39 scores before and after training. 0 to 3 points
can be assigned for each item of the PDQ-39. In the BELA and
the FKK, the patients themselves were asked to rate the effect
of training on each item (got worse, a little worse, no change, a
little better, much better). Item scores accordingly ranged from
−2 to 2. The scales of the PDQ-39 were inverted for consistency
in analysis, so that a high score would indicate an improvement
in all scales.
MANOVA was performed to compare general effects of
training in both groups on the basis of the overall sum difference
in the PDQ-39 and the change score of the sum in BELA and
FKK.
Because of the small sample size and the large number
of subscales, the differences in the PDQ-39, BELA and FKK
subscales were calculated with ANOVA.
Predictor Variables
To find possible variables that might predict outcome variables
in the intervention group, a Spearman correlation was generated
between outcome variables and all possible variables at baseline.
The putative predictors were subjected to multiple regression
analysis.
RESULTS
Baseline Characteristics of the Two
Study Groups
The characteristics of the two study groups at baseline are
shown in Table 1. We considered any findings with p < 0.05
to be statistically significant. The two groups did not differ
significantly at baseline with respect to age, sex, educational level,
disease duration, fatigue, apathy, sleepiness, depression, anxiety,
or MMSE and UPDRS III scores.
Intergroup Differences of Changes in
Stress and the Quality of Life
These results are shown in Table 2 (MANOVA). The two groups
differed significantly with respect to stress as assessed by the
BELA (p = 0.026), with a large effect size (η2 = 0.139) and
likewise as assessed by the FKK (p= 0.037, η2 = 0.118) in favor of
the intervention group. Therefore, the impact of CBT on patients
with PD is more effective than the impact of HEP. The control
TABLE 2 | Change scores relating to stress and quality of life.
Change score
CBT mean (SD) HEP mean (SD) p Effect size (η2)
BELA 5.56 (11.48) −2.75 (9.36) 0.03a 0.14
FKK sum 4.68 (5.98) 1.07 (2.28) 0.04a 0.12
PDQ-39 sum 5.31 (13.94) 3.25 (6.30) 0.03a 0.13
BELA, Belastungsfragebogen für Parkinsonpatienten; FKK, Fragebogen
zur Krankheitsbezo-genen Kommunikation; PDQ-39 , Parkinson’s Disease
Questionnaire. The statistical test used was multiple analysis of variance
(MANOVA). A positive mean implies a benefit; aSignificant at the 5% level.
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group showed a negative change score in BELA, which indicates
an increase in stress after receiving the HEP.
The sum score of the PDQ-39 differed significantly between
the groups (p = 0.03), indicating an improved QoL after CBT
training, with a large effect size (η2 = 0.13).
Intergroup Differences of Changes in
Stress and Quality of Life Subscales
Subscale analyses were performed to determine which subscales
made the greatest contributions to the observed intergroup
differences. As shown in Table 3, score changes on the
“emotional well-being” and “somatic motor function” subscales
of the BELA were significantly better in the CBT group
than in the HEP group after training — for emotional well-
being, p = 0.033, η2 = 0.124; for somatic motor function,
p = 0.039, η2 = 0.115. These two effects were of medium
strength. Also, in these two subscales, there is a negative effect
for the HEP group, indicating a deterioration of perceived
emotional wellbeing and somatic motoric functioning after
the training for the control group. There was no significant
difference between groups in score changes on the “cognitive
ability” subscale. As for the FKK subscales, the CBT group did
significantly better on the social skills subscale than the HEP
group (p = 0.031), meaning that skills which enable social
interactions, with a nearly large effect size (η2 = 0.127). There
was no significant difference in the social burden subscale (see
Table 3).
There were no significant intergroup differences between
score changes on any of the PDQ-39 subscales, such as
TABLE 3 | Change score in subscales of stress and quality of life.
Change score
CBT mean
(SD)
HEP mean
(SD)
p η2
BELA
Emotional 3.56 (6.14) −0.38 (4.09) 0.033a 0.124
Somatic motor function 1.18 (3.70) −1.38 (3.81) 0.039a 0.115
Cognitive 0.50 (1.50) −0.30 (0.94) 0.054 0.096
FKK
Social burden 1.81 (2.80) 0.38 (1.19) 0.06 0.09
Social skills 2.94 (3.71) 0.69 (1.25) 0.03a 0.13
PDQ-39
Mobility 5.19 (17.82) 3.42 (9.47) 0.07 0.08
Daily activities 6.80 (17.04) 1.67 (9.37) 0.07 0.09
Emotional well-being 0.50 (7.80) 1.33 (7.84) 0.27 0.01
Stigma 0.31 (11.32) 0.50 (10.86) 0.43 0.00
Social support 0.13 (19.43) 2.75 (5.45) 0.33 0.01
Cognition 4.81 (12.73) 0.42 (12.23) 0.14 0.04
Communication 4.70 (18.42) 3.58 (11.03) 0.42 0.00
Physical discomfort 3.67 (13.93) 8.33 (10.03) 0.17 0.03
BELA, Belastungsfragebogen für Parkinsonpatienten; FKK, Fragebogen
zur Krankheits-bezogenen Kommunikation; PDQ-39, Parkinson‘s Disease
Questionnaire. Tests were Analysis of Variance (ANOVA). A positive mean implies
a benefit; aSignificant at the 5% level.
“mobility,” “daily activities,” “emotional wellbeing,” “stigma,”
“social support,” “cognition,” “communication” and “physical
discomfort.” When divided in subscales, the PDQ-39 does not
show a greater improvement in QoL for the CBT group compared
to the HEP group.
Predictors
A correlation matrix was conducted to find possible predictor
variables in the intervention group. The change in the overall
score of PDQ-39 is correlated significantly with disease duration
(r = 0.527; p = 0.036) and age (r = 0.507; p = 0.045). The
correlation between the initial UPDRSIII score and outcome in
terms of the change in the overall PDQ-39 score did not reach
statistical significance (r = 0.472; p = 0.065). Variables were
analyzed in a multiple regression for PDQ-39 demonstrating that
disease duration influences the training effect in terms of QoL,
if separately analyzed (β = 0.53; R2 = 0.23). The significance of
disease duration disappears if integrated in one model with age.
Youth predicts a better effect of training on QoL; i.e., younger
patients have a greater improvement in QoL after group CBT
(β= 0.56; R2 = 0.49) (Table 4).
DISCUSSION
In this study, we examined whether cognitive behavioral group
therapy lessens stress and improves QoL in PD patients more
effectively than a HEP. We found that it does, and that the effect is
mostly accounted for by a worsening of BELA and PDQ-39 scores
in the control (HEP) group. Similar findings were seen on all
subscales except for the communication and physical discomfort
subscales of the PDQ-39, on which all patients showed a decline.
These results are comparable to earlier findings: Tiihonen et al.
(2008) analyzed the effect of group CBT versus no treatment
in PD patients with PD and found that the CBT patients die
significantly better in terms of QOL as assessed by the PDQ-
39, the difference being accounted for by a worsened QoL in the
control group.
When interpreting the findings of this and other trials
involving PD patients, one must bear in mind the progressive
TABLE 4 | Multiple regression on PDQ-39 measured in intervention group
(n = 16).
Independent
variable
B (SE) β Corr. R2 F
Model1 0.23 5.56
Disease Duration 0.11 (0.04) 0.53a
Model2 0.49 8.12
Disease duration
Age
0.07 (0.04)
0.31 (0.31)
0.33
0.56a
Model3 0.52 6.35
Disease duration
Age
UPDRS III
0.05 (0.04)
0.76 (0.32)
0.45 (0.33)
0.24
0.47a
0.28
PDQ-39, Parkinson’s Disease Questionnaire 39; UPDRS III, Unified Parkinson’s
Disease Rating Scale cognitive deficits; aSignificant at the 5% level.
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nature of the disease. The control group received physiotherapy,
music therapy, and dietary counseling. The CBT training was
intended to improve the patients’ emotional and social skills, so
that they would suffer less from stress due to the manifestations
of PD and would achieve a higher QoL despite progression of
the disease. Patients in the CBT group received training that
was focused on coping with the disease the development of
self-efficacy (belief in one’s own ability to perform tasks and
reach goals). Previous studies have revealed that self-efficacy
contributes to a high QoL and a low stress level (Tiihonen et al.,
2008). We think the worsening QoL in the control (HEP) group
of this study may well have been due in large part to these patients’
increased distress over their progressive physical limitations. The
BELA consists of questions about the emotional burden resulting
from a variety of problems (anxiety, etc.), rather than these
problems themselves. As HEP is focused on physical training
rather than emotional burden reduction, one may speculate that
the patients in our control group may even have experienced
the HEP training itself as stressful, which, in turn, may have
contributed to or accounted for their lower BELA change score.
Likewise, in the PDQ-39, many of the items whose frequency
the patients are asked to estimate are themselves feelings, such
as worry about other people’s reactions. In this case as well, HEP
training is not specifically directed against such items and could
conceivably even make them worse.
Both groups reported increased physical discomfort after
training. This shows that the CBT group did not experience better
physical well-being through the development of strategies to deal
with the disease itself, and that the HEP intervention did not
improve the physical manifestations of the disease sufficiently
to improve physical comfort. Perhaps coping with the disease
is more important than direct treatment of its manifestations.
In one study, a higher optimism score was correlated with
lesser severity of disease (Shifren, 1996), indicating that disease
severity is influenced by the patient’s perception. It follows that
a treatment focused on a change in attitude toward the disease
could be beneficial.
This study also shows that younger patients with PD show a
larger improvement in QoL after CBT than older patients. The
older patients in this study had generally suffered from PD for
a longer time (p = 0.026); the effect of disease duration as a
predictor disappears in the regression model with age. Younger
patients, who generally have had the disease for a shorter time
and have more years left to live, may well be better motivated
to cope with the disease than older ones. Stanley et al. (2009)
reported in their study using CBT for treating general anxiety
disorder (GAD), greater effect sizes in younger patients than
in older ones. To minimize this effect, Laidlaw et al. (2008),
developed CBT concept specifically for elderly patients. The
authors suggested to focus on issues that are explicitly related to
this age, such as physical health, role characteristics, losses and
relationship to younger generations. Even though we did have
age related issues in the CBT treatment of this study, they were
not discussed deeper. Instead we focused on disease-related issues
where patients learned to restructure the negative associations
with the disease, (e.g., being ashamed of it).
CBT activates the prefrontal cortex that is responsible for the
process and regulation of emotions (Goldapple et al., 2004). This
effect can be applied to any patient; therefore it can be used
for a variety of patient groups. The review article of (Berardelli
et al., 2015) shows that previous studies examining movement
disorders found a reduction of depressive symptoms and an
increase of QoL after receiving CBT. In a study using CBT on
patient’s with multiple sclerosis, patients have shown a better QoL
after the treatment. This effect was mediated by depression (Cosio
et al., 2011). These findings show, that CBT can generally have an
impact on QoL in patient’s with physical diseases.
The small scale of this study limits the interpretation of its
findings. Because of the small number of observations, MANOVA
could not be applied to all variables, and ANOVA had to be used
instead, yielding less detailed findings. If more patients had been
included in this study, its findings would have been more robust.
Moreover, this study did not include either a group of healthy
subjects without PD or a group of PD patients who did not receive
any training at all. Either or both of these negative controls
might have revealed general training effects that this study, as
performed, could not address. For future studies, a larger number
of observations as well as a group of healthy participants would
be necessary to reveal well funded statements.
With these limitations, this study indicate the possibility that
CBT lessened stress and improved QoL to a greater extent than
HEP in – particularly younger – patients with PD. We conclude
that group CBT might be a promising treatment for preventing
increased stress and a declining QoL in patients with PD.
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